Director/PDMR Shareholding
Updated : 09:50
23 October 2020
James Fisher and Sons plc ("FSJ.L")
Grant of Sharesave options and notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulations
James Fisher and Sons plc ("James Fisher") was notified that on 21 October 2020, options were granted under the James Fisher and Sons plc 2015 Sharesave Scheme. The Sharesave Scheme is an all-employee share plan and executive directors are eligible to participate on the same terms as other eligible employees. Details of the options granted to the executive directors are set out below:
Name | Position | Number of shares
| Exercise Price (£) | Expected Maturity Date |
Eoghan O'Lionaird | Chief Executive Officer | 2,935
| 10.22 | 1 December 2025 |
Stuart Kilpatrick | Group Finance Director | 2,935
| 10.22 | 1 December 2025 |
This announcement, including the notification below, is made in accordance with the requirements of the EU Market Abuse Regulation.
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Eoghan O'Lionaird | ||||||||
2 | Reason for Notification | |||||||||
a) | Position/status | Chief Executive Officer (PDMR) | ||||||||
b) | Initial notification/Amendment | Initial notification | ||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | James Fisher and Sons plc | ||||||||
b) | LEI | 213800J975E5OYR6S216 | ||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 25 pence each in James Fisher and Sons plc GB0003395000 | ||||||||
b) | Nature of the transaction | Grant of an option to acquire ordinary shares under the James Fisher and Sons plc 2015 Sharesave Plan which will become exercisable on 1 December 2025. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information - Aggregated volume - Price |
2935
£10.22
| ||||||||
e) | Date of the transaction | 21 October 2020 | ||||||||
f) | Place of the transaction | Outside a trading venue | ||||||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Stuart Kilpatrick | ||||||||
2 | Reason for Notification | |||||||||
a) | Position/status | Group Finance Director (PDMR) | ||||||||
b) | Initial notification/Amendment | Initial notification | ||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | James Fisher and Sons plc | ||||||||
b) | LEI | 213800J975E5OYR6S216 | ||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 25 pence each in James Fisher and Sons plc GB0003395000 | ||||||||
b) | Nature of the transaction | Grant of an option to acquire ordinary shares under the James Fisher and Sons plc 2015 Sharesave Plan which will become exercisable on 1 December 2025. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information - Aggregated volume - Price |
2935
£10.22
| ||||||||
e) | Date of the transaction | 21 October 2020 | ||||||||
f) | Place of the transaction | Outside a trading venue | ||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.